Review





Similar Products

99
ATCC flp in t rex hek293 cells
a Cartoon depicting the E3-MKLN1–Sub-MKLN1 tetrameric assembly, highlighting the discoidin and Kelch domains, and Asn447 within Kelch domain Loop-1 (starred), which is central to the E3-MKLN1–Sub-MKLN1 interface. b Cartoon depicting the Kelch domain central channel, which recognizes the C-terminal Arg of ZMYND19 and FAM72A, highlighting contact residues Gly273, Trp291, and Tyr346 (starred). c In vitro ubiquitylation assay comparing CTLH MKLN1 WT and the N447R mutant toward MKLN1, ZMYND19, and FAM72A-UNG2, n = 3 technical replicates. d Immunoblot analysis of MKLN1 levels in MKLN1-deficient cells transiently expressing WT, W291A/G273W, or N447R 3×Flag-MKLN1 , monitoring Torin1-dependent degradation after 16 h, Torin1 + MG132 (16 h) co-treatment, or matched DMSO controls. Actin serves as a loading control. e Quantification of MKLN1 immunoblots from ( d ). Data from each well were normalized to actin, and then each set expressing a particular 3×Flag-MKLN1 construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 4 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). f Top: sequence alignment of MKLN1, ZMYND19, and FAM72A C-termini. Bottom: superposition of cryo-EM structures of FAM72A (blue) and ZMYND19 (magenta) C-termini bound within the E3-MKLN1 Kelch domain central channel, highlighting their similar contacts between MKLN1 Gly273, Trp291, Tyr346, Arg407, and Arg517, and the terminal Arg residues of FAM72A (Arg149) and ZMYND19 (Arg227). g In vitro ubiquitylation assay examining effect of W291A/G273W Kelch central channel mutant on CTLH MKLN1 activity toward MKLN1, ZMYND19 and FAM72A-UNG2, n = 3 technical replicates. h Co-immunoprecipitation (using anti-RANBP9 antibody) in MKLN1- and ZMYND19-deficient <t>HEK293</t> cells transiently expressing HA-ZMYND19 and 3×Flag-MKLN1 (WT or indicated N447R, or W291A/G273W mutants), assessing the role of Kelch channel surfaces on ZMYND19 association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 2 biological replicates). i Immunoblot analysis of UNG and FAM72A levels in MKLN1 −/− knockout HEK293 cells transiently co-transfected with constructs expressing FAM72A and 3×Flag-MKLN1 WT or indicated mutant versions (W291A/G273W, or N447R) following mock (DMSO) treatment or treatment with proteasome inhibitor MG132. j Quantification of UNG2 immunoblots from ( i ). Data from each well were normalized to actin, and then to the DMSO control for cells transfected with a construct expressing WT 3×Flag-MKLN1 . The graph shows results of mean ± s.d. of n = 3 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.1). k Fluorescence polarization assay measuring binding of fluorescein-labeled peptides corresponding to the C-terminal 19 residues of ZMYND19 or FAM72A to the various versions of the MKLN1 Kelch domain (WT, W291A/G273W, or W291A/Y346A). K D for the ZMYND19 peptide–WT MKLN1 interaction is indicated. Data shown are the mean ± s.d. ( n = 3 technical replicates). l Co-immunoprecipitation via anti-RANBP9 antibody or rabbit IgG as a negative control in parental and ZMYND19 −/− knockout HEK293 cells transfected with constructs expressing HA-ZMYND19 (WT, ΔC-ter 3 res, or ΔC-ter Arg), assessing the role of the ZMYND19 C-terminal region in association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 5 biological replicates). m Immunoblot analysis of ZMYND19 and MKLN1 levels in ZMYND19 −/− knockout HEK293 cells transiently expressing HA-ZMYND19 WT or ΔC-ter Arg mutant, and treated either with DMSO as control, Torin1, or Torin1 and proteasome inhibitor MG132. Actin serves as a loading control. n Quantification of ZMYND19 immunoblots from ( m ). Data from each well were normalized to actin, and then each set transfected with a particular HA-ZMYND19 expression construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 5 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). In vitro ubiquitylation assays examining the effect of C-terminal mutations in ZMYND19 ( o ) or FAM72A ( p ) on ubiquitylation by CTLH MKLN1 . n = 2 technical replicates. Source data are provided as a file.
Flp In T Rex Hek293 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hek293+t+cells/293/pmc13676621-480-0-4
Average 99 stars, based on 1 article reviews
flp in t rex hek293 cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC hek293 t cells
a Cartoon depicting the E3-MKLN1–Sub-MKLN1 tetrameric assembly, highlighting the discoidin and Kelch domains, and Asn447 within Kelch domain Loop-1 (starred), which is central to the E3-MKLN1–Sub-MKLN1 interface. b Cartoon depicting the Kelch domain central channel, which recognizes the C-terminal Arg of ZMYND19 and FAM72A, highlighting contact residues Gly273, Trp291, and Tyr346 (starred). c In vitro ubiquitylation assay comparing CTLH MKLN1 WT and the N447R mutant toward MKLN1, ZMYND19, and FAM72A-UNG2, n = 3 technical replicates. d Immunoblot analysis of MKLN1 levels in MKLN1-deficient cells transiently expressing WT, W291A/G273W, or N447R 3×Flag-MKLN1 , monitoring Torin1-dependent degradation after 16 h, Torin1 + MG132 (16 h) co-treatment, or matched DMSO controls. Actin serves as a loading control. e Quantification of MKLN1 immunoblots from ( d ). Data from each well were normalized to actin, and then each set expressing a particular 3×Flag-MKLN1 construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 4 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). f Top: sequence alignment of MKLN1, ZMYND19, and FAM72A C-termini. Bottom: superposition of cryo-EM structures of FAM72A (blue) and ZMYND19 (magenta) C-termini bound within the E3-MKLN1 Kelch domain central channel, highlighting their similar contacts between MKLN1 Gly273, Trp291, Tyr346, Arg407, and Arg517, and the terminal Arg residues of FAM72A (Arg149) and ZMYND19 (Arg227). g In vitro ubiquitylation assay examining effect of W291A/G273W Kelch central channel mutant on CTLH MKLN1 activity toward MKLN1, ZMYND19 and FAM72A-UNG2, n = 3 technical replicates. h Co-immunoprecipitation (using anti-RANBP9 antibody) in MKLN1- and ZMYND19-deficient <t>HEK293</t> cells transiently expressing HA-ZMYND19 and 3×Flag-MKLN1 (WT or indicated N447R, or W291A/G273W mutants), assessing the role of Kelch channel surfaces on ZMYND19 association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 2 biological replicates). i Immunoblot analysis of UNG and FAM72A levels in MKLN1 −/− knockout HEK293 cells transiently co-transfected with constructs expressing FAM72A and 3×Flag-MKLN1 WT or indicated mutant versions (W291A/G273W, or N447R) following mock (DMSO) treatment or treatment with proteasome inhibitor MG132. j Quantification of UNG2 immunoblots from ( i ). Data from each well were normalized to actin, and then to the DMSO control for cells transfected with a construct expressing WT 3×Flag-MKLN1 . The graph shows results of mean ± s.d. of n = 3 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.1). k Fluorescence polarization assay measuring binding of fluorescein-labeled peptides corresponding to the C-terminal 19 residues of ZMYND19 or FAM72A to the various versions of the MKLN1 Kelch domain (WT, W291A/G273W, or W291A/Y346A). K D for the ZMYND19 peptide–WT MKLN1 interaction is indicated. Data shown are the mean ± s.d. ( n = 3 technical replicates). l Co-immunoprecipitation via anti-RANBP9 antibody or rabbit IgG as a negative control in parental and ZMYND19 −/− knockout HEK293 cells transfected with constructs expressing HA-ZMYND19 (WT, ΔC-ter 3 res, or ΔC-ter Arg), assessing the role of the ZMYND19 C-terminal region in association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 5 biological replicates). m Immunoblot analysis of ZMYND19 and MKLN1 levels in ZMYND19 −/− knockout HEK293 cells transiently expressing HA-ZMYND19 WT or ΔC-ter Arg mutant, and treated either with DMSO as control, Torin1, or Torin1 and proteasome inhibitor MG132. Actin serves as a loading control. n Quantification of ZMYND19 immunoblots from ( m ). Data from each well were normalized to actin, and then each set transfected with a particular HA-ZMYND19 expression construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 5 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). In vitro ubiquitylation assays examining the effect of C-terminal mutations in ZMYND19 ( o ) or FAM72A ( p ) on ubiquitylation by CTLH MKLN1 . n = 2 technical replicates. Source data are provided as a file.
Hek293 T Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hek293+t+cells/293/bio_rxiv__64898__2026__10__13__758962-351-0-5
Average 99 stars, based on 1 article reviews
hek293 t cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

95
MedChemExpress hek293 cells
a Cartoon depicting the E3-MKLN1–Sub-MKLN1 tetrameric assembly, highlighting the discoidin and Kelch domains, and Asn447 within Kelch domain Loop-1 (starred), which is central to the E3-MKLN1–Sub-MKLN1 interface. b Cartoon depicting the Kelch domain central channel, which recognizes the C-terminal Arg of ZMYND19 and FAM72A, highlighting contact residues Gly273, Trp291, and Tyr346 (starred). c In vitro ubiquitylation assay comparing CTLH MKLN1 WT and the N447R mutant toward MKLN1, ZMYND19, and FAM72A-UNG2, n = 3 technical replicates. d Immunoblot analysis of MKLN1 levels in MKLN1-deficient cells transiently expressing WT, W291A/G273W, or N447R 3×Flag-MKLN1 , monitoring Torin1-dependent degradation after 16 h, Torin1 + MG132 (16 h) co-treatment, or matched DMSO controls. Actin serves as a loading control. e Quantification of MKLN1 immunoblots from ( d ). Data from each well were normalized to actin, and then each set expressing a particular 3×Flag-MKLN1 construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 4 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). f Top: sequence alignment of MKLN1, ZMYND19, and FAM72A C-termini. Bottom: superposition of cryo-EM structures of FAM72A (blue) and ZMYND19 (magenta) C-termini bound within the E3-MKLN1 Kelch domain central channel, highlighting their similar contacts between MKLN1 Gly273, Trp291, Tyr346, Arg407, and Arg517, and the terminal Arg residues of FAM72A (Arg149) and ZMYND19 (Arg227). g In vitro ubiquitylation assay examining effect of W291A/G273W Kelch central channel mutant on CTLH MKLN1 activity toward MKLN1, ZMYND19 and FAM72A-UNG2, n = 3 technical replicates. h Co-immunoprecipitation (using anti-RANBP9 antibody) in MKLN1- and ZMYND19-deficient <t>HEK293</t> cells transiently expressing HA-ZMYND19 and 3×Flag-MKLN1 (WT or indicated N447R, or W291A/G273W mutants), assessing the role of Kelch channel surfaces on ZMYND19 association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 2 biological replicates). i Immunoblot analysis of UNG and FAM72A levels in MKLN1 −/− knockout HEK293 cells transiently co-transfected with constructs expressing FAM72A and 3×Flag-MKLN1 WT or indicated mutant versions (W291A/G273W, or N447R) following mock (DMSO) treatment or treatment with proteasome inhibitor MG132. j Quantification of UNG2 immunoblots from ( i ). Data from each well were normalized to actin, and then to the DMSO control for cells transfected with a construct expressing WT 3×Flag-MKLN1 . The graph shows results of mean ± s.d. of n = 3 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.1). k Fluorescence polarization assay measuring binding of fluorescein-labeled peptides corresponding to the C-terminal 19 residues of ZMYND19 or FAM72A to the various versions of the MKLN1 Kelch domain (WT, W291A/G273W, or W291A/Y346A). K D for the ZMYND19 peptide–WT MKLN1 interaction is indicated. Data shown are the mean ± s.d. ( n = 3 technical replicates). l Co-immunoprecipitation via anti-RANBP9 antibody or rabbit IgG as a negative control in parental and ZMYND19 −/− knockout HEK293 cells transfected with constructs expressing HA-ZMYND19 (WT, ΔC-ter 3 res, or ΔC-ter Arg), assessing the role of the ZMYND19 C-terminal region in association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 5 biological replicates). m Immunoblot analysis of ZMYND19 and MKLN1 levels in ZMYND19 −/− knockout HEK293 cells transiently expressing HA-ZMYND19 WT or ΔC-ter Arg mutant, and treated either with DMSO as control, Torin1, or Torin1 and proteasome inhibitor MG132. Actin serves as a loading control. n Quantification of ZMYND19 immunoblots from ( m ). Data from each well were normalized to actin, and then each set transfected with a particular HA-ZMYND19 expression construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 5 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). In vitro ubiquitylation assays examining the effect of C-terminal mutations in ZMYND19 ( o ) or FAM72A ( p ) on ubiquitylation by CTLH MKLN1 . n = 2 technical replicates. Source data are provided as a file.
Hek293 Cells, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hek293+t+cells/Thioflavin+T/pm42770703-387-7-16
Average 95 stars, based on 1 article reviews
hek293 cells - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

99
ATCC hek293 t cells atcc using lipofectamine2000
a Cartoon depicting the E3-MKLN1–Sub-MKLN1 tetrameric assembly, highlighting the discoidin and Kelch domains, and Asn447 within Kelch domain Loop-1 (starred), which is central to the E3-MKLN1–Sub-MKLN1 interface. b Cartoon depicting the Kelch domain central channel, which recognizes the C-terminal Arg of ZMYND19 and FAM72A, highlighting contact residues Gly273, Trp291, and Tyr346 (starred). c In vitro ubiquitylation assay comparing CTLH MKLN1 WT and the N447R mutant toward MKLN1, ZMYND19, and FAM72A-UNG2, n = 3 technical replicates. d Immunoblot analysis of MKLN1 levels in MKLN1-deficient cells transiently expressing WT, W291A/G273W, or N447R 3×Flag-MKLN1 , monitoring Torin1-dependent degradation after 16 h, Torin1 + MG132 (16 h) co-treatment, or matched DMSO controls. Actin serves as a loading control. e Quantification of MKLN1 immunoblots from ( d ). Data from each well were normalized to actin, and then each set expressing a particular 3×Flag-MKLN1 construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 4 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). f Top: sequence alignment of MKLN1, ZMYND19, and FAM72A C-termini. Bottom: superposition of cryo-EM structures of FAM72A (blue) and ZMYND19 (magenta) C-termini bound within the E3-MKLN1 Kelch domain central channel, highlighting their similar contacts between MKLN1 Gly273, Trp291, Tyr346, Arg407, and Arg517, and the terminal Arg residues of FAM72A (Arg149) and ZMYND19 (Arg227). g In vitro ubiquitylation assay examining effect of W291A/G273W Kelch central channel mutant on CTLH MKLN1 activity toward MKLN1, ZMYND19 and FAM72A-UNG2, n = 3 technical replicates. h Co-immunoprecipitation (using anti-RANBP9 antibody) in MKLN1- and ZMYND19-deficient <t>HEK293</t> cells transiently expressing HA-ZMYND19 and 3×Flag-MKLN1 (WT or indicated N447R, or W291A/G273W mutants), assessing the role of Kelch channel surfaces on ZMYND19 association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 2 biological replicates). i Immunoblot analysis of UNG and FAM72A levels in MKLN1 −/− knockout HEK293 cells transiently co-transfected with constructs expressing FAM72A and 3×Flag-MKLN1 WT or indicated mutant versions (W291A/G273W, or N447R) following mock (DMSO) treatment or treatment with proteasome inhibitor MG132. j Quantification of UNG2 immunoblots from ( i ). Data from each well were normalized to actin, and then to the DMSO control for cells transfected with a construct expressing WT 3×Flag-MKLN1 . The graph shows results of mean ± s.d. of n = 3 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.1). k Fluorescence polarization assay measuring binding of fluorescein-labeled peptides corresponding to the C-terminal 19 residues of ZMYND19 or FAM72A to the various versions of the MKLN1 Kelch domain (WT, W291A/G273W, or W291A/Y346A). K D for the ZMYND19 peptide–WT MKLN1 interaction is indicated. Data shown are the mean ± s.d. ( n = 3 technical replicates). l Co-immunoprecipitation via anti-RANBP9 antibody or rabbit IgG as a negative control in parental and ZMYND19 −/− knockout HEK293 cells transfected with constructs expressing HA-ZMYND19 (WT, ΔC-ter 3 res, or ΔC-ter Arg), assessing the role of the ZMYND19 C-terminal region in association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 5 biological replicates). m Immunoblot analysis of ZMYND19 and MKLN1 levels in ZMYND19 −/− knockout HEK293 cells transiently expressing HA-ZMYND19 WT or ΔC-ter Arg mutant, and treated either with DMSO as control, Torin1, or Torin1 and proteasome inhibitor MG132. Actin serves as a loading control. n Quantification of ZMYND19 immunoblots from ( m ). Data from each well were normalized to actin, and then each set transfected with a particular HA-ZMYND19 expression construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 5 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). In vitro ubiquitylation assays examining the effect of C-terminal mutations in ZMYND19 ( o ) or FAM72A ( p ) on ubiquitylation by CTLH MKLN1 . n = 2 technical replicates. Source data are provided as a file.
Hek293 T Cells Atcc Using Lipofectamine2000, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hek293+t+cells/293T%2F17/pm42632785-62-21-24
Average 99 stars, based on 1 article reviews
hek293 t cells atcc using lipofectamine2000 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC hek293 t crl 3216 cells
a Cartoon depicting the E3-MKLN1–Sub-MKLN1 tetrameric assembly, highlighting the discoidin and Kelch domains, and Asn447 within Kelch domain Loop-1 (starred), which is central to the E3-MKLN1–Sub-MKLN1 interface. b Cartoon depicting the Kelch domain central channel, which recognizes the C-terminal Arg of ZMYND19 and FAM72A, highlighting contact residues Gly273, Trp291, and Tyr346 (starred). c In vitro ubiquitylation assay comparing CTLH MKLN1 WT and the N447R mutant toward MKLN1, ZMYND19, and FAM72A-UNG2, n = 3 technical replicates. d Immunoblot analysis of MKLN1 levels in MKLN1-deficient cells transiently expressing WT, W291A/G273W, or N447R 3×Flag-MKLN1 , monitoring Torin1-dependent degradation after 16 h, Torin1 + MG132 (16 h) co-treatment, or matched DMSO controls. Actin serves as a loading control. e Quantification of MKLN1 immunoblots from ( d ). Data from each well were normalized to actin, and then each set expressing a particular 3×Flag-MKLN1 construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 4 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). f Top: sequence alignment of MKLN1, ZMYND19, and FAM72A C-termini. Bottom: superposition of cryo-EM structures of FAM72A (blue) and ZMYND19 (magenta) C-termini bound within the E3-MKLN1 Kelch domain central channel, highlighting their similar contacts between MKLN1 Gly273, Trp291, Tyr346, Arg407, and Arg517, and the terminal Arg residues of FAM72A (Arg149) and ZMYND19 (Arg227). g In vitro ubiquitylation assay examining effect of W291A/G273W Kelch central channel mutant on CTLH MKLN1 activity toward MKLN1, ZMYND19 and FAM72A-UNG2, n = 3 technical replicates. h Co-immunoprecipitation (using anti-RANBP9 antibody) in MKLN1- and ZMYND19-deficient <t>HEK293</t> cells transiently expressing HA-ZMYND19 and 3×Flag-MKLN1 (WT or indicated N447R, or W291A/G273W mutants), assessing the role of Kelch channel surfaces on ZMYND19 association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 2 biological replicates). i Immunoblot analysis of UNG and FAM72A levels in MKLN1 −/− knockout HEK293 cells transiently co-transfected with constructs expressing FAM72A and 3×Flag-MKLN1 WT or indicated mutant versions (W291A/G273W, or N447R) following mock (DMSO) treatment or treatment with proteasome inhibitor MG132. j Quantification of UNG2 immunoblots from ( i ). Data from each well were normalized to actin, and then to the DMSO control for cells transfected with a construct expressing WT 3×Flag-MKLN1 . The graph shows results of mean ± s.d. of n = 3 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.1). k Fluorescence polarization assay measuring binding of fluorescein-labeled peptides corresponding to the C-terminal 19 residues of ZMYND19 or FAM72A to the various versions of the MKLN1 Kelch domain (WT, W291A/G273W, or W291A/Y346A). K D for the ZMYND19 peptide–WT MKLN1 interaction is indicated. Data shown are the mean ± s.d. ( n = 3 technical replicates). l Co-immunoprecipitation via anti-RANBP9 antibody or rabbit IgG as a negative control in parental and ZMYND19 −/− knockout HEK293 cells transfected with constructs expressing HA-ZMYND19 (WT, ΔC-ter 3 res, or ΔC-ter Arg), assessing the role of the ZMYND19 C-terminal region in association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 5 biological replicates). m Immunoblot analysis of ZMYND19 and MKLN1 levels in ZMYND19 −/− knockout HEK293 cells transiently expressing HA-ZMYND19 WT or ΔC-ter Arg mutant, and treated either with DMSO as control, Torin1, or Torin1 and proteasome inhibitor MG132. Actin serves as a loading control. n Quantification of ZMYND19 immunoblots from ( m ). Data from each well were normalized to actin, and then each set transfected with a particular HA-ZMYND19 expression construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 5 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). In vitro ubiquitylation assays examining the effect of C-terminal mutations in ZMYND19 ( o ) or FAM72A ( p ) on ubiquitylation by CTLH MKLN1 . n = 2 technical replicates. Source data are provided as a file.
Hek293 T Crl 3216 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hek293+t+cells/293T/pm42320680-165-0-6
Average 99 stars, based on 1 article reviews
hek293 t crl 3216 cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC embryonic kidney cell line hek293 t
a Cartoon depicting the E3-MKLN1–Sub-MKLN1 tetrameric assembly, highlighting the discoidin and Kelch domains, and Asn447 within Kelch domain Loop-1 (starred), which is central to the E3-MKLN1–Sub-MKLN1 interface. b Cartoon depicting the Kelch domain central channel, which recognizes the C-terminal Arg of ZMYND19 and FAM72A, highlighting contact residues Gly273, Trp291, and Tyr346 (starred). c In vitro ubiquitylation assay comparing CTLH MKLN1 WT and the N447R mutant toward MKLN1, ZMYND19, and FAM72A-UNG2, n = 3 technical replicates. d Immunoblot analysis of MKLN1 levels in MKLN1-deficient cells transiently expressing WT, W291A/G273W, or N447R 3×Flag-MKLN1 , monitoring Torin1-dependent degradation after 16 h, Torin1 + MG132 (16 h) co-treatment, or matched DMSO controls. Actin serves as a loading control. e Quantification of MKLN1 immunoblots from ( d ). Data from each well were normalized to actin, and then each set expressing a particular 3×Flag-MKLN1 construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 4 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). f Top: sequence alignment of MKLN1, ZMYND19, and FAM72A C-termini. Bottom: superposition of cryo-EM structures of FAM72A (blue) and ZMYND19 (magenta) C-termini bound within the E3-MKLN1 Kelch domain central channel, highlighting their similar contacts between MKLN1 Gly273, Trp291, Tyr346, Arg407, and Arg517, and the terminal Arg residues of FAM72A (Arg149) and ZMYND19 (Arg227). g In vitro ubiquitylation assay examining effect of W291A/G273W Kelch central channel mutant on CTLH MKLN1 activity toward MKLN1, ZMYND19 and FAM72A-UNG2, n = 3 technical replicates. h Co-immunoprecipitation (using anti-RANBP9 antibody) in MKLN1- and ZMYND19-deficient <t>HEK293</t> cells transiently expressing HA-ZMYND19 and 3×Flag-MKLN1 (WT or indicated N447R, or W291A/G273W mutants), assessing the role of Kelch channel surfaces on ZMYND19 association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 2 biological replicates). i Immunoblot analysis of UNG and FAM72A levels in MKLN1 −/− knockout HEK293 cells transiently co-transfected with constructs expressing FAM72A and 3×Flag-MKLN1 WT or indicated mutant versions (W291A/G273W, or N447R) following mock (DMSO) treatment or treatment with proteasome inhibitor MG132. j Quantification of UNG2 immunoblots from ( i ). Data from each well were normalized to actin, and then to the DMSO control for cells transfected with a construct expressing WT 3×Flag-MKLN1 . The graph shows results of mean ± s.d. of n = 3 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.1). k Fluorescence polarization assay measuring binding of fluorescein-labeled peptides corresponding to the C-terminal 19 residues of ZMYND19 or FAM72A to the various versions of the MKLN1 Kelch domain (WT, W291A/G273W, or W291A/Y346A). K D for the ZMYND19 peptide–WT MKLN1 interaction is indicated. Data shown are the mean ± s.d. ( n = 3 technical replicates). l Co-immunoprecipitation via anti-RANBP9 antibody or rabbit IgG as a negative control in parental and ZMYND19 −/− knockout HEK293 cells transfected with constructs expressing HA-ZMYND19 (WT, ΔC-ter 3 res, or ΔC-ter Arg), assessing the role of the ZMYND19 C-terminal region in association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 5 biological replicates). m Immunoblot analysis of ZMYND19 and MKLN1 levels in ZMYND19 −/− knockout HEK293 cells transiently expressing HA-ZMYND19 WT or ΔC-ter Arg mutant, and treated either with DMSO as control, Torin1, or Torin1 and proteasome inhibitor MG132. Actin serves as a loading control. n Quantification of ZMYND19 immunoblots from ( m ). Data from each well were normalized to actin, and then each set transfected with a particular HA-ZMYND19 expression construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 5 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). In vitro ubiquitylation assays examining the effect of C-terminal mutations in ZMYND19 ( o ) or FAM72A ( p ) on ubiquitylation by CTLH MKLN1 . n = 2 technical replicates. Source data are provided as a file.
Embryonic Kidney Cell Line Hek293 T, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hek293+t+cells/293T/pm42221821-251-13-18
Average 99 stars, based on 1 article reviews
embryonic kidney cell line hek293 t - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

86
Procell Inc hek293 t cells
a Cartoon depicting the E3-MKLN1–Sub-MKLN1 tetrameric assembly, highlighting the discoidin and Kelch domains, and Asn447 within Kelch domain Loop-1 (starred), which is central to the E3-MKLN1–Sub-MKLN1 interface. b Cartoon depicting the Kelch domain central channel, which recognizes the C-terminal Arg of ZMYND19 and FAM72A, highlighting contact residues Gly273, Trp291, and Tyr346 (starred). c In vitro ubiquitylation assay comparing CTLH MKLN1 WT and the N447R mutant toward MKLN1, ZMYND19, and FAM72A-UNG2, n = 3 technical replicates. d Immunoblot analysis of MKLN1 levels in MKLN1-deficient cells transiently expressing WT, W291A/G273W, or N447R 3×Flag-MKLN1 , monitoring Torin1-dependent degradation after 16 h, Torin1 + MG132 (16 h) co-treatment, or matched DMSO controls. Actin serves as a loading control. e Quantification of MKLN1 immunoblots from ( d ). Data from each well were normalized to actin, and then each set expressing a particular 3×Flag-MKLN1 construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 4 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). f Top: sequence alignment of MKLN1, ZMYND19, and FAM72A C-termini. Bottom: superposition of cryo-EM structures of FAM72A (blue) and ZMYND19 (magenta) C-termini bound within the E3-MKLN1 Kelch domain central channel, highlighting their similar contacts between MKLN1 Gly273, Trp291, Tyr346, Arg407, and Arg517, and the terminal Arg residues of FAM72A (Arg149) and ZMYND19 (Arg227). g In vitro ubiquitylation assay examining effect of W291A/G273W Kelch central channel mutant on CTLH MKLN1 activity toward MKLN1, ZMYND19 and FAM72A-UNG2, n = 3 technical replicates. h Co-immunoprecipitation (using anti-RANBP9 antibody) in MKLN1- and ZMYND19-deficient <t>HEK293</t> cells transiently expressing HA-ZMYND19 and 3×Flag-MKLN1 (WT or indicated N447R, or W291A/G273W mutants), assessing the role of Kelch channel surfaces on ZMYND19 association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 2 biological replicates). i Immunoblot analysis of UNG and FAM72A levels in MKLN1 −/− knockout HEK293 cells transiently co-transfected with constructs expressing FAM72A and 3×Flag-MKLN1 WT or indicated mutant versions (W291A/G273W, or N447R) following mock (DMSO) treatment or treatment with proteasome inhibitor MG132. j Quantification of UNG2 immunoblots from ( i ). Data from each well were normalized to actin, and then to the DMSO control for cells transfected with a construct expressing WT 3×Flag-MKLN1 . The graph shows results of mean ± s.d. of n = 3 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.1). k Fluorescence polarization assay measuring binding of fluorescein-labeled peptides corresponding to the C-terminal 19 residues of ZMYND19 or FAM72A to the various versions of the MKLN1 Kelch domain (WT, W291A/G273W, or W291A/Y346A). K D for the ZMYND19 peptide–WT MKLN1 interaction is indicated. Data shown are the mean ± s.d. ( n = 3 technical replicates). l Co-immunoprecipitation via anti-RANBP9 antibody or rabbit IgG as a negative control in parental and ZMYND19 −/− knockout HEK293 cells transfected with constructs expressing HA-ZMYND19 (WT, ΔC-ter 3 res, or ΔC-ter Arg), assessing the role of the ZMYND19 C-terminal region in association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 5 biological replicates). m Immunoblot analysis of ZMYND19 and MKLN1 levels in ZMYND19 −/− knockout HEK293 cells transiently expressing HA-ZMYND19 WT or ΔC-ter Arg mutant, and treated either with DMSO as control, Torin1, or Torin1 and proteasome inhibitor MG132. Actin serves as a loading control. n Quantification of ZMYND19 immunoblots from ( m ). Data from each well were normalized to actin, and then each set transfected with a particular HA-ZMYND19 expression construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 5 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). In vitro ubiquitylation assays examining the effect of C-terminal mutations in ZMYND19 ( o ) or FAM72A ( p ) on ubiquitylation by CTLH MKLN1 . n = 2 technical replicates. Source data are provided as a file.
Hek293 T Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hek293+t+cells/cells+hek293t/pmc13266310-249-0-2
Average 86 stars, based on 1 article reviews
hek293 t cells - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


a Cartoon depicting the E3-MKLN1–Sub-MKLN1 tetrameric assembly, highlighting the discoidin and Kelch domains, and Asn447 within Kelch domain Loop-1 (starred), which is central to the E3-MKLN1–Sub-MKLN1 interface. b Cartoon depicting the Kelch domain central channel, which recognizes the C-terminal Arg of ZMYND19 and FAM72A, highlighting contact residues Gly273, Trp291, and Tyr346 (starred). c In vitro ubiquitylation assay comparing CTLH MKLN1 WT and the N447R mutant toward MKLN1, ZMYND19, and FAM72A-UNG2, n = 3 technical replicates. d Immunoblot analysis of MKLN1 levels in MKLN1-deficient cells transiently expressing WT, W291A/G273W, or N447R 3×Flag-MKLN1 , monitoring Torin1-dependent degradation after 16 h, Torin1 + MG132 (16 h) co-treatment, or matched DMSO controls. Actin serves as a loading control. e Quantification of MKLN1 immunoblots from ( d ). Data from each well were normalized to actin, and then each set expressing a particular 3×Flag-MKLN1 construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 4 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). f Top: sequence alignment of MKLN1, ZMYND19, and FAM72A C-termini. Bottom: superposition of cryo-EM structures of FAM72A (blue) and ZMYND19 (magenta) C-termini bound within the E3-MKLN1 Kelch domain central channel, highlighting their similar contacts between MKLN1 Gly273, Trp291, Tyr346, Arg407, and Arg517, and the terminal Arg residues of FAM72A (Arg149) and ZMYND19 (Arg227). g In vitro ubiquitylation assay examining effect of W291A/G273W Kelch central channel mutant on CTLH MKLN1 activity toward MKLN1, ZMYND19 and FAM72A-UNG2, n = 3 technical replicates. h Co-immunoprecipitation (using anti-RANBP9 antibody) in MKLN1- and ZMYND19-deficient HEK293 cells transiently expressing HA-ZMYND19 and 3×Flag-MKLN1 (WT or indicated N447R, or W291A/G273W mutants), assessing the role of Kelch channel surfaces on ZMYND19 association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 2 biological replicates). i Immunoblot analysis of UNG and FAM72A levels in MKLN1 −/− knockout HEK293 cells transiently co-transfected with constructs expressing FAM72A and 3×Flag-MKLN1 WT or indicated mutant versions (W291A/G273W, or N447R) following mock (DMSO) treatment or treatment with proteasome inhibitor MG132. j Quantification of UNG2 immunoblots from ( i ). Data from each well were normalized to actin, and then to the DMSO control for cells transfected with a construct expressing WT 3×Flag-MKLN1 . The graph shows results of mean ± s.d. of n = 3 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.1). k Fluorescence polarization assay measuring binding of fluorescein-labeled peptides corresponding to the C-terminal 19 residues of ZMYND19 or FAM72A to the various versions of the MKLN1 Kelch domain (WT, W291A/G273W, or W291A/Y346A). K D for the ZMYND19 peptide–WT MKLN1 interaction is indicated. Data shown are the mean ± s.d. ( n = 3 technical replicates). l Co-immunoprecipitation via anti-RANBP9 antibody or rabbit IgG as a negative control in parental and ZMYND19 −/− knockout HEK293 cells transfected with constructs expressing HA-ZMYND19 (WT, ΔC-ter 3 res, or ΔC-ter Arg), assessing the role of the ZMYND19 C-terminal region in association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 5 biological replicates). m Immunoblot analysis of ZMYND19 and MKLN1 levels in ZMYND19 −/− knockout HEK293 cells transiently expressing HA-ZMYND19 WT or ΔC-ter Arg mutant, and treated either with DMSO as control, Torin1, or Torin1 and proteasome inhibitor MG132. Actin serves as a loading control. n Quantification of ZMYND19 immunoblots from ( m ). Data from each well were normalized to actin, and then each set transfected with a particular HA-ZMYND19 expression construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 5 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). In vitro ubiquitylation assays examining the effect of C-terminal mutations in ZMYND19 ( o ) or FAM72A ( p ) on ubiquitylation by CTLH MKLN1 . n = 2 technical replicates. Source data are provided as a file.

Journal: Nature Communications

Article Title: Multimodal substrate recruitment enables CTLH MKLN1 E3 ligase to target acetylated N-, C-, and internal degrons

doi: 10.1038/s41467-026-78311-4

Figure Lengend Snippet: a Cartoon depicting the E3-MKLN1–Sub-MKLN1 tetrameric assembly, highlighting the discoidin and Kelch domains, and Asn447 within Kelch domain Loop-1 (starred), which is central to the E3-MKLN1–Sub-MKLN1 interface. b Cartoon depicting the Kelch domain central channel, which recognizes the C-terminal Arg of ZMYND19 and FAM72A, highlighting contact residues Gly273, Trp291, and Tyr346 (starred). c In vitro ubiquitylation assay comparing CTLH MKLN1 WT and the N447R mutant toward MKLN1, ZMYND19, and FAM72A-UNG2, n = 3 technical replicates. d Immunoblot analysis of MKLN1 levels in MKLN1-deficient cells transiently expressing WT, W291A/G273W, or N447R 3×Flag-MKLN1 , monitoring Torin1-dependent degradation after 16 h, Torin1 + MG132 (16 h) co-treatment, or matched DMSO controls. Actin serves as a loading control. e Quantification of MKLN1 immunoblots from ( d ). Data from each well were normalized to actin, and then each set expressing a particular 3×Flag-MKLN1 construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 4 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). f Top: sequence alignment of MKLN1, ZMYND19, and FAM72A C-termini. Bottom: superposition of cryo-EM structures of FAM72A (blue) and ZMYND19 (magenta) C-termini bound within the E3-MKLN1 Kelch domain central channel, highlighting their similar contacts between MKLN1 Gly273, Trp291, Tyr346, Arg407, and Arg517, and the terminal Arg residues of FAM72A (Arg149) and ZMYND19 (Arg227). g In vitro ubiquitylation assay examining effect of W291A/G273W Kelch central channel mutant on CTLH MKLN1 activity toward MKLN1, ZMYND19 and FAM72A-UNG2, n = 3 technical replicates. h Co-immunoprecipitation (using anti-RANBP9 antibody) in MKLN1- and ZMYND19-deficient HEK293 cells transiently expressing HA-ZMYND19 and 3×Flag-MKLN1 (WT or indicated N447R, or W291A/G273W mutants), assessing the role of Kelch channel surfaces on ZMYND19 association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 2 biological replicates). i Immunoblot analysis of UNG and FAM72A levels in MKLN1 −/− knockout HEK293 cells transiently co-transfected with constructs expressing FAM72A and 3×Flag-MKLN1 WT or indicated mutant versions (W291A/G273W, or N447R) following mock (DMSO) treatment or treatment with proteasome inhibitor MG132. j Quantification of UNG2 immunoblots from ( i ). Data from each well were normalized to actin, and then to the DMSO control for cells transfected with a construct expressing WT 3×Flag-MKLN1 . The graph shows results of mean ± s.d. of n = 3 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.1). k Fluorescence polarization assay measuring binding of fluorescein-labeled peptides corresponding to the C-terminal 19 residues of ZMYND19 or FAM72A to the various versions of the MKLN1 Kelch domain (WT, W291A/G273W, or W291A/Y346A). K D for the ZMYND19 peptide–WT MKLN1 interaction is indicated. Data shown are the mean ± s.d. ( n = 3 technical replicates). l Co-immunoprecipitation via anti-RANBP9 antibody or rabbit IgG as a negative control in parental and ZMYND19 −/− knockout HEK293 cells transfected with constructs expressing HA-ZMYND19 (WT, ΔC-ter 3 res, or ΔC-ter Arg), assessing the role of the ZMYND19 C-terminal region in association with the CTLH complex. Immunoprecipitates and inputs are shown. Actin serves as a loading control ( n = 5 biological replicates). m Immunoblot analysis of ZMYND19 and MKLN1 levels in ZMYND19 −/− knockout HEK293 cells transiently expressing HA-ZMYND19 WT or ΔC-ter Arg mutant, and treated either with DMSO as control, Torin1, or Torin1 and proteasome inhibitor MG132. Actin serves as a loading control. n Quantification of ZMYND19 immunoblots from ( m ). Data from each well were normalized to actin, and then each set transfected with a particular HA-ZMYND19 expression construct was normalized to the DMSO control for that construct. The graph shows results of mean ± s.d. of n = 5 biological replicates. P -values were calculated using two-way ANOVA with Dunnett’s multiple comparison tests ( p -value significance <0.05). In vitro ubiquitylation assays examining the effect of C-terminal mutations in ZMYND19 ( o ) or FAM72A ( p ) on ubiquitylation by CTLH MKLN1 . n = 2 technical replicates. Source data are provided as a file.

Article Snippet: Flp-In T-Rex HEK293 cells (ATCC CRL-1573) were purchased from Thermo Fisher Scientific (catalog no. R78007 ).

Techniques: In Vitro, Ubiquitin Assay, Mutagenesis, Western Blot, Analysis, Expressing, Control, Construct, Comparison, Sequencing, Cryo-Electron Microscopy, Activity Assay, Co-Immunoprecipitation Assay, Knock-Out, Transfection, Fluorescence, Binding Assay, Labeling, Negative Control